Michael V. Quinn
Sales & Marketing at JDS Therapeutics LLC
Profile
Michael V.
Quinn is currently the Vice President-Sales at JDS Therapeutics LLC.
Previously, he worked as the Director-National Sales Training at Noven Therapeutics LLC.
He completed his undergraduate degree at The Trustees of Columbia University in The City of New York.
Michael V. Quinn active positions
Companies | Position | Start |
---|---|---|
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | Sales & Marketing | 2012-03-31 |
Former positions of Michael V. Quinn
Companies | Position | End |
---|---|---|
Noven Therapeutics LLC
Noven Therapeutics LLC Pharmaceuticals: MajorHealth Technology Noven Therapeutics LLC develops and distributes pharmaceutical products. It markets products which include Pexeva used for major depressive disorder, panic disorder (PD), obsessive compulsive disorder (OCD) and Lithobid for bipolar disorder. The company was founded by Phillip M. Satow and Michael S. Satow in 2003 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Training of Michael V. Quinn
The Trustees of Columbia University in The City of New York | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | Health Technology |
Noven Therapeutics LLC
Noven Therapeutics LLC Pharmaceuticals: MajorHealth Technology Noven Therapeutics LLC develops and distributes pharmaceutical products. It markets products which include Pexeva used for major depressive disorder, panic disorder (PD), obsessive compulsive disorder (OCD) and Lithobid for bipolar disorder. The company was founded by Phillip M. Satow and Michael S. Satow in 2003 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Michael V. Quinn